Sterling Capital Management’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.34K Buy
4,342
+3,023
+229% +$8.52K ﹤0.01% 2610
2026
Q2
$4.1K Buy
+1,319
New +$4.34K ﹤0.01% 2728
2025
Q2
– Sell
-636
Closed -$881 – 3283
2025
Q1
$881 Sell
636
-543
-46% -$1.16K ﹤0.01% 2855
2024
Q4
$2.68K Buy
1,179
+1,063
+916% +$3.73K ﹤0.01% 2699
2024
Q3
$548 Buy
+116
New +$671 ﹤0.01% 2827

Other funds holding CABA

Sterling Capital Management's CABA Position: Q3 2026 in Review

Sterling Capital Management increased its Cabaletta Bio (CABA) stake by 229% in Q3 2026, buying an estimated $8.52K and bringing the position to 4,342 shares worth $8.34K. The position accounts for ﹤0.01% of the portfolio, ranked #2610.

Sterling Capital Management first reported a position in CABA in Q3 2024 and has held it in 5 quarters since. 161 funds tracked by Wall St. Rank hold CABA as of Q3 2026.

  • Sterling Capital Management held 4,342 shares of Cabaletta Bio worth $8.34K as of Q3 2026.
  • Sterling Capital Management bought 3,023 Cabaletta Bio shares in Q3 2026, an estimated $8.52K.
  • Cabaletta Bio made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2610 holding.
  • Sterling Capital Management first reported a position in Cabaletta Bio in Q3 2024 and has held it in 5 quarters since.
  • 161 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.